期刊文献+

3-氯代亚甲基色满-4-酮类化合物的设计、合成及体外抗真菌活性研究 被引量:2

Design,synthesis and in vitro antifungal activity of 3-substituted-methylenechroman-4-ones
原文传递
导出
摘要 本文以取代苯酚为原料,经微波条件下的取代反应和多聚磷酸中进行的环合反应制备了取代色满酮,取代色满酮与甲酸乙酯的缩合产物经氯化反应制备了3-氯代亚甲基色满-4-酮类化合物,共合成了10种未见文献报道的新化合物。化合物结构经质谱和核磁共振氢谱进行了确证,并且采用二倍稀释法对目标化合物的体外抗真菌活性进行了测试,结果表明它们具有很好的体外抗真菌活性,其中化合物4c、4e、4g和4h对石膏样小孢子菌的MIC值为1μg.mL1,高于对照药氟康唑和两性霉素B,具有进一步研究价值。 Substituted phenols as the starting materials were transformed into substituted chromanones by substitution reaction and cyclization reaction,and then 3-(hydroxymethylene)chroman-4-ones were synthesized from substituted chromanones by condensation reaction;at last,the target compounds were synthesized from 3-(hydroxymethylene)chroman-4-ones by chlorination reaction.Their structures were confirmed by 1H NMR and MS.The antifungal activity of the target compounds in vitro was measured by consecutive double dilution,and the result of antifungal experiment indicated that the target compounds had good antifungal action on most fungi tested in vitro.The MIC value of compounds 4c,4e,4g and 4h on M.gypseum is 1 μg-mL-1,better than fluconazole and amphotericin B.
出处 《药学学报》 CAS CSCD 北大核心 2012年第5期614-618,共5页 Acta Pharmaceutica Sinica
基金 国家“重大新药创制”科技重大专项资助项目(2012ZX09103-101-057) 国家自然科学基金资助项目(21175031) 河北省教育厅基金资助项目(ZD2010234,2011159) 河北省科技厅基金资助项目(11966411D) 河北省药物质量分析控制重点实验室基金资助项目(09265631D-14) 河北大学基金资助项目(2010Q33)
关键词 色满酮 3-氯代亚甲基色满-4-酮 抗真菌活性 chromanones 3-(chloromethylene)chroman-4-one antifungal activity
  • 相关文献

参考文献5

二级参考文献63

  • 1胡春,肖高铿,于新章,王永永,付守廷,计志忠,刘百里.4-色满酮Mannich碱类化合物的合成及其抗炎活性[J].中国药物化学杂志,2004,14(4):209-214. 被引量:11
  • 2李慧媛,胡春.4-色酮类和4-色满酮类化合物生物活性研究概况[J].中国药学杂志,2005,40(4):241-244. 被引量:14
  • 3陈海涛,计志忠.含有α-亚甲基-γ-丁内酯的天然产物及其结构类似物的抗癌、抗炎活性[J].中国药物化学杂志,1994,4(2):137-149. 被引量:13
  • 4Eggler J F, Marfat A. Preparation of substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases[P]. EP: 313 295, 1991-02-06.
  • 5Guenter J, Winfried O, Bem R, et al. Seitenkettenchlrierungen Von N-Hereocyclen mit Trichlorisocyanursaeure (TCC) [J]. Chem Ber, 1987, 120: 649-651.
  • 6Fitton A O, Ramage G R. Dihydropyranochromones derivatives fromquinol [J].J Chem Soc, 1963, 11: 5426-5430.
  • 7Siddaiah V, Rao C V, Venkateswarlu S, et al. Synthesis, stereochemical assignments, and biological activities of homoisoflavonoids[J]. BioorgMed Chem, 2006, 14 (8): 2 545- 2 551.
  • 8Colonge P J,Guyot A.Etudesurles chromanones-4.I.Asyloxy-3 alcanoiques[J].Bull Chem Soe Fr,1957,10:1 228-1 231.
  • 9Powell S G,Johnson N G.Beta-toloxypropionic acid and the corresponding chromanones[J].J Am Chem Soc,1924,46(12):2861-2 863.
  • 10Wiley P F.Amebacidal chromanones[J].J Am Chem Soc,1951,73 (9):4205-4209.

共引文献27

同被引文献19

  • 1林洁,张鹏,郑智慧,董悦生,路新华,张华.真菌来源的乙酰胆碱酯酶抑制剂F01-2076A的研究[J].河北大学学报(自然科学版),2006,26(1):47-50. 被引量:2
  • 2BAU~OIS B, DAUZONNE D. Aminopeptidase-N/CD13(EC3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects[J]. Med Res Rev, 2006, 26(1): 88-130.
  • 3SCARPINI E, SCHELTENS P, FELDMAN H. Treatment of Alzheimer's disease: current status and new perspectives[J]. Lancet Neurol, 2003, 2(9): 539-547.
  • 4TALESA V N. Acetyleholinesterase in Alzheimer's disease [J]. Mech Ageing Dev, 2001, 122(16): 1961-1969.
  • 5VEITCH N C, GRAYER R J. Flavonoids and their glycosides, including anthocyanins [J]. Nat Prod Rep, 2008, 25(3): 555 - 611.
  • 6SHENG Rong, LIN Xiao, ZHANG Jing, et al. Design synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors [J]. Bioorg Med Chem, 2009, 17(18): 6692-6698.
  • 7BARTUS R T,DEAN III L D,BEER B,et al. The cholinergic hypothesis of geriatric memory dysfunction . Science,1982,217(30):408-417.
  • 8GLENNER G G,WONG C E. Alzheimer’s disease and Down’s syndrome: Sharing of a unique cerebrovascular amyloid fibril protein . Biochem Biophys Res Co,1984,122(3): 1131-1135.
  • 9G LENNER G G,WONG C E. Alzheimer’s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein . Biochem Biophys Res Co,1984,120(3): 885-890.
  • 10SCARPINI E,SCHELTENS P,FELDMAN H. Treatment of Alzheimer′s disease: current status and new perspectives . Lancet Neurol,2003,2(9): 539-547.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部